Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2005
11/24/2005US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
11/24/2005US20050260211 Drug delivery; delivering a non-cytotoxic therapeutic moiety into nerve cells; nerve growth factor
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005US20050260174 Systems and methods for treating patients with processed lipoaspirate cells
11/24/2005CA2821239A1 Phycotoxins and uses thereof
11/24/2005CA2566721A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2566210A1 Oxo-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2565984A1 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
11/24/2005CA2565514A1 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
11/24/2005CA2565051A1 Novel use of peptide compounds for treating dyskinesia
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
11/23/2005EP1598365A1 Protection of endogenous therapeutic peptides
11/23/2005EP1598355A1 Therapeutic agent for schizophrenia
11/23/2005EP1598349A1 Novel 2-pyridinecarboxamide derivatives
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1598072A1 Medical drug containing fine particle of noble metal
11/23/2005EP1598071A1 Superoxide anion decomposing agent
11/23/2005EP1598068A1 Antipsychotic heterocycle compounds
11/23/2005EP1598066A1 Powder inhalant of sumatriptan and the method of preparation thereof
11/23/2005EP1598065A2 Drugs for improving prognosis of brain injury
11/23/2005EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
11/23/2005EP1597355A2 Method and materials relating to neurogenesis
11/23/2005EP1597261A1 Substituted amino heterocycles as vr-1 antagonists for treating pain
11/23/2005EP1597258A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use
11/23/2005EP1597243A1 Heterocyclic compounds useful as nurr-1 activators
11/23/2005EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies
11/23/2005EP1596867A2 Treatment of psychosis with a muscarinic m1 receptor ectopic activator
11/23/2005EP1596866A2 Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
11/23/2005EP1596865A1 Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain
11/23/2005EP1596861A1 Pharmaceutical combinations comprising a nos inhibitor and an nmda receptor antagonist
11/23/2005EP1596856A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/23/2005EP1596852A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds
11/23/2005EP1596845A1 Therapeutic use of acyl glycerols and the nitrogen- and sulphur-containing analogues therof
11/23/2005EP1596809A2 Abeta binding molecules
11/23/2005EP1467718B1 Method of treatment of a patient requiring analgesia
11/23/2005EP1463721B1 Compounds for imaging alzheimer's disease
11/23/2005EP1446015A4 Remodeling of tissues and organs
11/23/2005EP1390055B1 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1343788B1 Imidazo-triazine derivatives as ligands for gaba receptors
11/23/2005EP1296686B1 Praziquantel compositions for treating diseases caused by a coccidia
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP1200831B1 Modulating binding site on potassium channels used for screening
11/23/2005EP1137401B1 Administration of neurotrophic agents to the central nervous system
11/23/2005EP1076559B1 Cabergoline and pramipexole for treating cns diseases, especially parkinson's disease
11/23/2005EP1007060B1 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
11/23/2005EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition
11/23/2005EP0958357B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/23/2005EP0934263B1 Non-immunosuppressant fkbp rotamase inhibitors
11/23/2005EP0906088B1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/23/2005EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/23/2005CN1701075A Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
11/23/2005CN1701074A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/23/2005CN1701073A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/23/2005CN1701068A Novel compounds and their use
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
11/23/2005CN1700922A 3, 10, and 12a substituted tetracycline compounds
11/23/2005CN1700920A Phophylactic and therapeutic use of hydroxysteroids
11/23/2005CN1700912A Choline ascorbate formulations
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/23/2005CN1699343A Polymorphs of donepezil hydrochloride and process for production
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228446C Conotoxin MVII A and Trx fusion protein and its expression and application
11/23/2005CN1228346C Short peptide and its derivative and medicine with them as active component and use thereof
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/23/2005CN1228082C Method for preparing pharmaceutics of hydrolysate of brain protein
11/23/2005CN1228079C Oral medicine for treating child restless syndrome
11/23/2005CN1228069C Instant plant composition for sobering up and preparing method thereof
11/23/2005CN1228046C Fluctin slow release tablet
11/23/2005CN1228043C Sustained release groundmass for highly soluble drugs
11/22/2005US6967259 Process for the preparation of Citalopram intermediate
11/22/2005US6967245 Ucp5
11/22/2005US6967216 Neuropeptide Y receptor modulators; treating eating disorders
11/22/2005US6967210 Multiple sclerosis, brain disorders, analgesics
11/22/2005US6967201 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
11/22/2005US6967197 Also used in production of tumor necrosis factor alpha
11/22/2005US6967196 Sulfonamide compounds and uses thereof
11/22/2005US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
11/22/2005US6967033 synergistic combination of Tanacetum parthenium, and Vitex agnus-castus and/or Cimicifuga racemosa; may further contain Zingiber officinale
11/22/2005CA2304722C Acidic addition salts of morphine alkaloids and the application thereof
11/22/2005CA2252806C Polymorphs of donepezil hydrochloride and process for production
11/17/2005WO2005108574A1 Gm1 PROMOTER AND USE THEREOF
11/17/2005WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents
11/17/2005WO2005108399A1 Imidazopyridine compound
11/17/2005WO2005108384A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108364A1 Piperazine derivatives of alkyl oxindoles
11/17/2005WO2005108363A1 Piperazine derivatives of alkyl oxindoles
11/17/2005WO2005107808A2 Combination of atypical antipsychotics and 5-ht1b receptor antagonists
11/17/2005WO2005107805A1 Aβ-PRODUCTION INHIBITOR
11/17/2005WO2005107775A1 Composition having effect of modulating autonomic nerves and method of using the same
11/17/2005WO2005107748A2 Method of tonic treatment with oxyphenbutazone derivatives
1 ... 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 ... 1833